NCT00308165View on ClinicalTrials.gov

Topotecan by Intracerebral Clysis for Recurrent Primary Malignant Brain Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

March 31, 2015

Study Completion Date

January 31, 2016

Conditions
Brain Neoplasms, Primary Malignant
Interventions
PROCEDURE

Convection-Enhanced Delivery

microinfusion pumps to deliver chemotherapy directly into brain tumors

DRUG

Topotecan

chemotherapeutic drug for the treatment of brain tumors

Trial Locations (1)

10032

Columbia University Medical Center Neurological Institute, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jeffrey N. Bruce

OTHER

NCT00308165 - Topotecan by Intracerebral Clysis for Recurrent Primary Malignant Brain Tumors | Biotech Hunter | Biotech Hunter